首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Inhibitition on H22 Allografts, HepG2 and SMMC-7721 Human Hepatoma Cells of Adlay Seed Extracts
【24h】

Inhibitition on H22 Allografts, HepG2 and SMMC-7721 Human Hepatoma Cells of Adlay Seed Extracts

机译:lay仁提取物对H22同种异体移植物,HepG2和SMMC-7721人肝癌细胞的抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

To examine the effects of effective chemical substances of adlay seed on the hepatoma in vitro and in vivo. H22 cancer-bearing mice were chosen to observe the effects of tumor inhibiting effective chemical substances of adlay seed, drug-containing serum were prepared by serum pharmacology method. MTT assay was used to observe the proliferation inhibition rate of HepG2 and SMMC-7721 cells after incubation with the drugs containing serum. The effective chemical substances of adlay seed could inhibit the growth of H22 cancer in mice, the tumor inhibition rate of the different concentration was 42.46, 38.05, 33.31 % and the drug-containing serum could obviously inhibit the growth of HepG2 and SMMC-7721 cells.The effective chemical substances of adlay seed has the effect on inhibiting the growth of hepatoma.
机译:在体外和体内研究ad仁种子有效化学物质对肝癌的影响。选择H22荷瘤小鼠观察抑制ad仁种子有效化学物质的作用,通过血清药理学方法制备含药血清。用MTT法观察含血清药物孵育后HepG2和SMMC-7721细胞的增殖抑制率。 lay仁有效化学物质可抑制小鼠H22癌的生长,不同浓度的肿瘤抑制率分别为42.46、38.05、33.31%,含药血清能明显抑制HepG2和SMMC-7721细胞的生长。 lay仁种子中的有效化学物质具有抑制肝癌生长的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号